Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial.

Akram, Javed; Azhar, Shehnoor; Shahzad, Muhammad; Latif, Waqas; Khan, Khalid Saeed

Akram, Javed; Azhar, Shehnoor; Shahzad, Muhammad; Latif, Waqas; Khan, Khalid Saeed.

Akram J; Vice Chancellor/Professor of Internal Medicine, University of Health Sciences, Lahore, Pakistan.
Azhar S; Public Health, University of Health Sciences, Lahore, Pakistan. shehnoor.azhar@gmail.com.
Shahzad M; Professor of Pharmacology, University of Health Sciences, Lahore, Pakistan.
Latif W; Data Analyst at University of Health Sciences, Lahore, Pakistan.
Khan KS; Distinguished Investigator at Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Trials ; 23(1): 150, 2022 Feb 15.

Article in English | MEDLINE | ID: covidwho-1709530

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2022 Document Type: Article Affiliation country: S13063-022-06080-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google